Publishing Scientific Papers with Potential Security Risks
The recent controversy over publication of scientific papers concerning the transmissibility of bird flu virus was reviewed in a new report by the Congressional Research Service. The report cautiously elucidates the relevant policy implications and considers the responses available to Congress.
“Because of the complexity of dual-use issues, analysis of a topic according to one set of policy priorities may lead to unforeseen complications due to its intersection with other policy priorities,” the report says. “For example, maximizing security may lead to detriments in public health and scientific advancement, while maximizing scientific advancement may lead to security risks.”
See Publishing Scientific Papers with Potential Security Risks: Issues for Congress, July 12, 2012.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.